In partnership with
February 4, 2026
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today’s edition starts in Oklahoma, where repeal talk is rising just as the state’s enforcement rebuild has begun to show real bite, shrinking the footprint and tightening the front door. We also track how rescheduling is starting to seep into the real economy through insurance and tax planning, plus Pennsylvania’s move to run legalization through the budget lane while pricing entry like a gated community. New Jersey’s incoming AG is signaling a tougher posture on smoke shops, and the hemp beverage lane keeps getting pulled into the same enforcement gravity.
Policy, Decoded is written daily by THC Group, where we advise operators, investors, trade groups, and governments on policy, regulatory, and political headaches that do not come with clean rulebooks. Today’s briefing is supported by Fintech Takes. Also, new episode of The Hybrid drops later this week, and we’re talking ballot questions and Super Bowl.
🗳️ Repeal talk meets cleanup reality
🧾 Rescheduling starts hitting balance sheets
🚬 Smoke shop enforcement heats up
Keep your hand on the holster.
If you work in fintech or finance, you already have too many tabs open and not enough time.
Fintech Takes is the free newsletter senior leaders actually read. Each week, I break down the trends, deals, and regulatory moves shaping the industry — and explain why they matter — in plain English.
No filler, no PR spin, and no “insights” you already saw on LinkedIn eight times this week. Just clear analysis and the occasional bad joke to make it go down easier.
Get context you can actually use. Subscribe free and see what’s coming before everyone else.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Governor Kevin Stitt used his State of the State address to call for sending Oklahoma's medical marijuana law back to voters and shutting it down, framing the program as a public safety problem tied to criminal activity. Attorney General Gentner Drummond went further, saying he wants the marijuana industry gone from Oklahoma and tying that position to Operation Blunt Force, a multi state black market trafficking case that resulted in 20 arrests and charges tied to straw ownership and diversion. Senate leadership is split on the idea. Senate President Pro Tempore Lonnie Paxton said a vote of the people is the clean path if repeal is the goal. Senate Minority Leader Julia Kirt pushed back, arguing lawmakers should respect state questions and focus on building workable guardrails.
What Stitt and Drummond are targeting is a program that has spent the last several years tightening. Oklahoma's medical marijuana program launched in 2018 with broad patient eligibility and an unusually open licensing model. The market expanded faster than governance capacity. In a few short years, the state was fighting problems that usually get handled at the front door: ownership screening, inspection coverage, and diversion controls. In 2022, lawmakers enacted a moratorium on new licenses and signaled a pivot from open entry to containment. In 2023, lawmakers extended that moratorium through August 1, 2026 and added national fingerprint based background checks, a property level limit on grow licenses, and expanded unannounced inspection authority across multiple agencies. OMMA commissioned a supply and demand study that found regulated supply vastly exceeded in state demand, using a 64 to 1 ratio to capture the diversion risk. Recent OMMA reporting reflects an agency operating in enforcement posture, with thousands of inspections and a large administrative case load alongside continuing license attrition.
This shift required regulators willing to make hard decisions and absorb the flack that comes along with that, and build muscle while the political class debated whether the whole experiment should exist. Adria Berry and her team took a program that was easy to caricature and did the unglamorous work of tightening it, step by step, in public, under pressure.
💡 Why It Matters: Oklahoma is following a playbook that has emerged in Maine, Massachusetts, and Arizona, where prohibitionist campaigns are trying to send voter approved legalization back to the ballot for repeal. The pitch is familiar: frame the program as unworkable, tie it to public safety problems, and argue the voters deserve another chance. What makes Oklahoma different is that the state actually did the work. Oklahoma built enforcement capacity and regulatory discipline over several years, shrinking the footprint and tightening controls while the program kept operating. Statewide officials are now using the problems that justified that cleanup as evidence the program should be eliminated, ignoring the progress made in addressing those very problems.
The political hazard is that successful enforcement gets reframed as proof the original design was unworkable, even when the enforcement is what made the system governable. High profile trafficking cases become fuel for rollback arguments, even when those cases prove enforcement tools are working. For operators, the risk is immediate. When the governor and attorney general both call for elimination rather than continued reform, compliance stops being a shield. Moratoria, shifting enforcement priorities, and public denunciations raise costs and freeze capital long before any repeal effort reaches the ballot. For patients, the stakes are access and stability. Hundreds of thousands of Oklahomans rely on this program, and political uncertainty about its future affects product availability, geographic coverage, and pricing today.
The legislative math still favors tightening over repeal. Passing licensing reforms and enforcement upgrades is easier than rolling back a voter approved program, and the Senate is already signaling that division. But rhetoric matters, because it shapes how businesses invest, how regulators prioritize, and how the public interprets enforcement headlines.
🧠 THC Group Take: Oklahoma's lesson is design, and the state is now living with the incentives it set at the beginning. The original framework made entry easy and volume attractive, which created room for diversion networks and paper control structures to hide inside a sea of legitimate licensees. The correction has been serious, and the pieces fit together: a moratorium to stop uncontrolled growth, stronger screening, multi agency inspection authority, and a commissioned study that gave lawmakers a defensible rationale for tightening.
Credit belongs where it is due. Adria Berry and OMMA were handed the tallest task in the building: rebuild credibility while the market kept moving, shrink the footprint without breaking patient access, and prove that enforcement can be aggressive without being careless. They worked to curb the Wild West narrative with discipline, maturity, and real backbone, often while taking punches from both sides. That matters because good governance is a force multiplier. It changes who stays, who invests, and who decides the state is no longer the easiest place in America to run a paper farm.
Calling for repeal now wastes the institutional capacity Oklahoma just built. The state has enforcement tools that work, a regulatory body that knows how to use them, and a shrinking license count that reflects real attrition of bad actors. Throwing that away to restart a ballot fight tells compliant operators to stop investing and tells illicit actors to wait out the politics. Progress matters. The durable endpoint is available: a smaller market with clean ownership files, routine inspections, track and trace analytics used as an intelligence tool, and rules that preserve patient access while making large scale diversion harder to hide. Oklahoma gets there by finishing the cleanup with boring competence and keeping the criminal problem separated from a medical lane that hundreds of thousands of residents still rely on. Repeal talk undermines that work, and it does so at exactly the moment the work is starting to pay off.
Fast-moving headlines, flagged for what matters.
An AM Best commentary argues that federal reclassification could make cannabis businesses look more like ordinary insureds, which is how national carriers start justifying entry. The near term driver is financial hygiene: 280E relief improves cash flow and reduces the cash heavy profile that has shaped underwriting and loss controls. An executive order does not create a safe harbor, and anti money laundering posture still chills broader participation without legislation. Pricing remains high for reasons that do not disappear overnight: limited loss data, high value inventory, and product liability claims tied to contamination and labeling. Rescheduling opens the door. Congress still controls whether anyone walks through it. (Risk & Insurance)
A Crain's Detroit Business opinion argues that moving cannabis to Schedule III could stabilize operators by restoring ordinary tax deductions under 280E and loosening some of the frictions that keep capital and insurance on the sidelines. The writer frames timing as mid to late 2026 for a final rule and ties the stakes to Michigan's new 24% wholesale excise tax, warning that higher legal prices can push consumers toward illicit supply. 280E relief can absorb part of the tax hit, protect payroll and retention, and keep smaller retailers from getting squeezed out first. The piece also points to secondary benefits from rescheduling: easier research pathways, reduced stigma for medical use, and incremental progress on banking access. (Crain’s Detroit Business)
Governor Josh Shapiro put adult use legalization back into Pennsylvania's 2026–2027 budget pitch and argued that federal rescheduling talk under President Trump lowers the political friction for Harrisburg to move. The proposal targets implementation on July 1st with retail sales projected to begin January 1, 2027, and pegs long run annual tax revenue around $200 million once the system is fully running. The budget also sketches a high barrier to entry for retailers: a $25 million initial licensing fee and a $500,000 annual renewal for dispensaries that convert and for new adult use retailers. Shapiro pairs the revenue case with an expungement and reinvestment frame, including restorative justice funding and money aimed at small and diverse businesses through agriculture. The state is pushing legalization through the budget lane while pricing access like a scarcity asset. (Marijuana Moment)
State and federal authorities announced the takedown of a sprawling black market marijuana operation in Oklahoma that prosecutors say moved roughly 1 million pounds of product with an estimated value of $1.5 billion. Investigators describe a straw owner scheme that allegedly used paid Oklahoma residents to secure grow licenses and registrations while real control and profits flowed elsewhere, then diverted product through a trafficking network. Officials said they executed more than 50 search warrants, seized firearms and cash, and charged 19 defendants across a racketeering and fraud package that includes conspiracy, document fraud, aggravated manufacturing, and unlawful proceeds. Attorney General Gentner Drummond touted the operation and said he wants the marijuana industry gone from Oklahoma, sharpening the line between tightening controls and attacking the program itself. Governor Kevin Stitt is already calling for a repeal vote, and cases like this one hand him the story he needs, even though the design failure sits in front end licensing and ownership controls that can be fixed without wiping out patient access. (KOCO 5)
Ohio Attorney General Dave Yost approved the revised ballot language for a referendum that would repeal core sections of SB 56, the new law that tightens the voter approved marijuana program and restricts intoxicating hemp sales. His certification clears the campaign to begin statewide signature gathering after he rejected an earlier version as misleading. Backers will need roughly 250,000 valid signatures to qualify, and the timing is unforgiving because SB 56 is slated to take effect in March. The fight is about more than hemp retail channels. Opponents argue the law also re criminalizes certain conduct and strips consumer protections that were embedded in the original legalization framework. If the signatures land on time, implementation pauses and Ohio voters get the final call at the ballot. (Marijuana Moment)
New Jersey's incoming attorney general, Jennifer Davenport, told senators she plans to coordinate a tougher enforcement posture against convenience stores and smoke shops selling illegal cannabis and intoxicating hemp products. Senators framed the problem as a vacuum of guidance and authority at the local level, with inconsistent ordinances and police uncertainty about what they can seize, cite, or shut down. Davenport said the legal market cannot thrive if the underground market keeps operating in plain sight and promised guidance and intelligence sharing with chiefs, county prosecutors, and state police. The hearing also surfaced the politics behind the push, with lawmakers pressing for new smoke shop legislation and a clearer statewide inventory framework so enforcement knows what is lawful on a shelf. Enforcement pressure will land hardest on unlicensed storefront retail. The compliant hemp beverage lane will need sharper category lines to avoid getting swept into a dragnet built for candy colored synthetics. (Heady NJ)
Massachusetts lawmakers are stitching together House and Senate cannabis reform bills in conference, with industry attorneys split on whether the package lands on the problems crushing operators right now. The draft menu runs wide: shrinking and restructuring the Cannabis Control Commission, raising the cap on how many retail licenses one entity can hold, expanding adult possession limits. Some lawyers see real relief in those levers, especially for a market living on thin margins and slow payments. Others are flagging provisions that could backfire, including debt and delinquency rules that may punish businesses already scraping to stay current (preach!). (Massachusetts Lawyers Weekly)
Nebraska lawmakers pressed advocates and industry on whether the Nebraska Medical Cannabis Commission is narrowing what voters approved in 2024, with Sen. John Cavanaugh pitching a bill to elect the five commissioners instead of leaving all appointments to the governor. The hearing landed in the middle of visible dysfunction: the commission met across the street and announced Chairwoman Monica Oldenburg resigned without explanation. Another bill would let the commission collect taxes or fees to fund basic infrastructure, after cultivators testified the agency lacks revenue, tracking systems, and seed to sale tools. Patient advocates warned that expanding authority for a commission they see as hostile will lock in barriers on product forms, providers, and access before the market launches. The commission's regulations hearing is set for February 26th in Lincoln. When the rulemaking body is this unstable before a single plant goes in the ground, operators are building compliance infrastructure around rules that may shift under political pressure. (Lincoln Journal Star)
Missouri lawmakers are weighing a bill to bring hemp derived THC beverages under an alcohol style framework as the products spread through convenience stores, dispensaries, and specialty shops with limited oversight. Sen. Mike Henderson's proposal would set a 21 plus age floor and apply a 7% excise tax that matches hard liquor rates, with a committee vote possible as soon as next week. A cited economic study pegs the category at roughly $75.4 million a year in potential annual impact for Missouri. A long time beverage distributor said the company wants in but needs clear rules before investing in a new lane. A hemp operator making low dose seltzers backed regulation too. When established distributors and manufacturers both ask for regulation, the current free for all is pricing risk higher than compliance costs. (KCTV5)
Indiana legislative leaders are telling advocates that marijuana legalization will not move in 2026, even as federal rescheduling talk drifts into statehouse conversations. Key Republicans are holding to the same posture: federal illegality keeps them on the sidelines. One pro reform lawmaker said he declined to file a bill because it had no path in a short session. The action is moving the other direction. The Senate advanced a bill to ban intoxicating and synthetic hemp derived products and to restrict sales and advertising near schools and playgrounds. Another measure targets billboard advertising for out of state dispensaries, with a hard removal deadline aimed at contracts signed to outrun last year's rule. Consumers keep crossing lines while the home state builds enforcement tools and political momentum for restrictions that make crossover traffic the only release valve for demand that is not going away. (Marijuana Moment)
A cannabis entrepreneur is urging the Fourth Circuit to revive a constitutional challenge to Maryland's social equity licensing framework, arguing that parts of the scoring system function as an in state preference. The dispute centers on whether Maryland's criteria effectively disadvantage non Maryland residents even when the program is framed as equity focused and facially neutral. The state is defending the structure as a lawful way to widen participation and correct historic exclusion without running a residency gate. Courts are still dividing on how far Dormant Commerce Clause doctrine reaches in a market that remains federally illegal, and litigants keep testing that seam state by state. If the challenge gains traction, it becomes a blueprint for suits that aim to unwind equity design through constitutional theory rather than legislatures. (Law360)
A prohibitionist campaign aiming to end Maine's adult use cannabis market failed to file signatures by the February 2nd deadline to reach the November 2026 ballot. The Maine Secretary of State's office confirmed the petitions were not returned. The group behind the measure now has until June 8, 2027 to collect 67,682 valid signatures for a November 2027 vote. Maine keeps operating under current law, and the political threat moved from sprint to marathon. Markets can absorb known timelines. What is harder to price is how much political energy prohibitionists can sustain over eighteen months, and whether the industry uses that window to build public support or just exhales and hopes the threat fades. (Cannabis Business Times)
The Office of Cannabis Regulation says a Canadian institution, Canada First Financial, is prepared to offer cannabis banking, including pre operational accounts for licensees. Regulators point to conditional cultivation and dispensary licenses already issued and a certified testing facility now in place, with planting expected within weeks. The plan on paper is regulated retail sales by fall 2026, which turns the next few months into a capacity test for seed to sale compliance, lab throughput, and inspection pacing. The same update carried a warning on intoxicating hemp rules and public consumption, with event permits set to go live February 6. Banking access is an accelerant, and it also makes enforcement cleaner because money moves through channels regulators can see. (Virgin Islands Consortium)
The deeper pattern behind today’s moves — and why it matters next.
🧾 Context: Medical cannabis now sits inside real treatment plans for nausea, pain, sleep, spasticity, and seizure disorders. U.S. oversight still runs through a state-by-state patchwork with inconsistent thresholds, uneven testing panels, and enforcement that often arrives after exposure. Microbial contamination persists inside regulated markets, and pathogenic Aspergillus has been detected in products that cleared culture-based screens. Chemical contaminants add cumulative risk and can plausibly shape drug metabolism in patient populations already living on tight therapeutic margins. Sampling remains the quiet structural weakness, because many states still let the regulated business choose the sample that defines the batch.
🔎 What It Signals: The market has outgrown standards built for agriculture and borrowed from food models, especially for inhaled products used by immunocompromised patients. Culture-based yeast and mold screens can create a false sense of safety when the clinical risk turns on pathogen-specific detection that better matches bedside reality. State reforms that reduce obvious lab shopping help, and they still leave incentives in place that can bend outcomes when sampling integrity is weak. International models show a more mature posture, with pharmacopoeial standards, validated methods, and distribution systems that treat medical cannabis like a medical product. Equity keeps showing up as a safety constraint, because patients priced out of regulated channels get pushed toward cheaper products with fewer safeguards.
🧠 THC Group Take: Safety reform starts with independent, regulator-controlled sampling, because the sample drives the truth of the certificate. States should move inhaled medical products to pathogen-specific molecular methods for organisms that drive clinical harm and publish lab performance in plain language that clinicians and patients can actually use. Chemical limits should align with pharmacopoeial expectations and converge across states, with less tolerance for zip-code variability in a category used daily by vulnerable patients. Enforcement should shift earlier in the product life cycle through randomized pulls, retained splits for referee testing, and routine data integrity checks. Pair the safety floor with affordability tools for medical patients so compliant product becomes the default choice, not a premium lane.
From the hearing room to the comment section — we’re watching it all.
👃 Aroma is becoming the real quality signal as sealed packaging pushed consumers into a THC numbers game. If the nose drives loyalty, brands will chase terpene consistency the way mainstream CPG chases flavor repeatability. (Forbes, Andrew DeAngelo)
🚗 Illinois sheriffs are trying to kill a persistent myth with a simple message: cannabis impairment behind the wheel is still a DUI. The campaign is a reminder that normalization moves faster than prevention, and enforcement is left cleaning up the worst outcomes. (WSJD, Illinois Sheriffs’ Association)
🗳️ Florida’s marijuana ballot fight is drifting into process warfare, with the campaign arguing thousands of petitions went uncounted and the state defending its handling. These disputes rarely change minds on legalization, and they can change trust in how ballot access works. (Action News Jax)
🧪 A group of Dutch MPs is pushing to phase out the regulated supply chain experiment, even as the governing coalition remains committed to continuing it and evaluating results. Markets price stability off governing commitments, and recurring political noise can still chill investment and compliance posture. (MMJDaily)